In Silico Drug Discovery
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,013
NCT01235546
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2011
Completion: Dec 31, 2015
Loading map...